Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
2000 1
2003 1
2004 1
2005 1
2006 2
2007 4
2008 3
2009 9
2010 12
2011 9
2012 19
2013 5
2014 4
2015 8
2016 5
2017 4
2018 5
2019 1
2021 2
2022 5
2023 12
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team. Baeten JM, et al. Among authors: stevens ws. N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11. N Engl J Med. 2012. PMID: 22784037 Free PMC article. Clinical Trial.
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance. Hamers RL, et al. Among authors: stevens ws. Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10. Int J Epidemiol. 2012. PMID: 21071386 Free PMC article. No abstract available.
Cross-municipality migration and spread of tuberculosis in South Africa.
Fofana AM, Moultrie H, Scott L, Jacobson KR, Shapiro AN, Dor G, Crankshaw B, Silva PD, Jenkins HE, Bor J, Stevens WS. Fofana AM, et al. Among authors: stevens ws. Sci Rep. 2023 Feb 15;13(1):2674. doi: 10.1038/s41598-023-29804-5. Sci Rep. 2023. PMID: 36792792 Free PMC article.
Xpert MTB/RIF Ultra 'trace': considerations for diagnostics.
Scott LE, da Silva MP, Marokane P, Jenkins HE, Stevens WS. Scott LE, et al. Among authors: stevens ws. Int J Tuberc Lung Dis. 2025 May 30;29(6):281-282. doi: 10.5588/ijtld.24.0411. Int J Tuberc Lung Dis. 2025. PMID: 40495300 No abstract available.
Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control.
Stevens WS, Scott L, Noble L, Gous N, Dheda K. Stevens WS, et al. Microbiol Spectr. 2017 Jan;5(1):10.1128/microbiolspec.tbtb2-0040-2016. doi: 10.1128/microbiolspec.TBTB2-0040-2016. Microbiol Spectr. 2017. PMID: 28155817 Free PMC article. Review.
117 results